Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Yves-Stephane Couture

Tracked across 2 events · 12 articles · First seen Jul 27, 2026 · Last active Aug 13, 2026

Sentiment
0
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
On August 13, 2026, Diagnosis Inc., a Canadian company specializing in AI-based early detection of eye diseases, announced that it received Medical Device Marketing Authorization for its CARA System from the Saudi Arabia — Saudi…
Impact: Yves-Stephane Couture, COO, called the authorization a milestone in commercialization efforts. His role is operational.
Aug 13, 2026 · 6 articles
2 0
Regulatory
Impact: Yves-Stephane Couture is COO of Diagnosis, expressed excitement about bringing CARA to Canadian optometrists.
Jul 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Yves-Stephane Couture live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.